Elafibranor for treating primary biliary cholangitis [ID6331]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Maralixibat for treating progressive familial intrahepatic cholestasis [ID3818]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Obeticholic acid for treating liver fibrosis in people with steatohepatitis [ID1645]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Odevixibat for treating cholestasis and pruritus in Alagille Syndrome [ID6181]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
OrganOx metra for liver transplant [ID5116]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Seladelpar for previously treated primary biliary cholangitis ID6429Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC